ARTICLE | Management Tracks
BioMarin CFO steps down; plus Atara, Epirium, Abalos, CytomX and more
February 6, 2020 1:24 AM UTC
Updated on Feb 6, 2020 at 2:27 AM UTC
Dan Spiegelman stepped down as EVP and CFO at BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to pursue other interests. SVP, Finance and Chief Accounting Officer Brian Mueller will serve as acting CFO as the rare diseases company searches internally and externally for a permanent successor.
Allogeneic T cell therapy company Atara Biotherapeutics Inc. (NASDAQ:ATRA) hired Kristin Yarema as chief commercial officer, effective Feb. 18. She was VP and therapeutic area head for global product strategy and commercial innovation in hematology and oncology at Amgen Inc. (NASDAQ:AMGN)...